Showing results (161-170 of 975) with videos related to
Sort By:
Pageof 98
Kidney360|April 4, 2022
Hyperaldosteronism: How Current Concepts Are Transforming the Diagnostic and Therapeutic ParadigmMichael R Lattanzio, Matthew R WeirCurrent Opinion in Nephrology and Hypertension|August 5, 2000
Theoretical basis and clinical evidence for differential effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor subtype 1 blockersM R Weir, W L HenrichThe New Zealand Medical Journal|February 24, 2001
Influenza vaccination coverage in Canterbury rest homesR Weir, L Jennings, C BruntonAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 8, 1999
Comparative cost-effectiveness of HMG-CoA reductase inhibitors in secondary prevention of acute myocardial infarctionW J Elliott, D R WeirInorganic Chemistry|October 24, 2001
Synthesis of Heteropolyoxometalate-Pillared Mg/Al, Mg/Ga, and Zn/Al Layered Double Hydroxides via LDH-Hydroxide PrecursorsMark R. Weir, Ronald A. KyddHeart (British Cardiac Society)|April 16, 2005
Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarctionR Weir, J J V McMurrayTransplantation|April 23, 2009
Minimizing the risk of chronic allograft nephropathyMatthew R Weir, Ravinder K WaliJoint Commission Journal on Quality and Patient Safety|February 14, 2009
Using implementation safety indicators for CPOE implementationCharlene R Weir, Cynthia A McCarthyPostgraduate Medicine|February 15, 1992
Risk for renal injury in diabetic hypertensive patients. The physiologic basis for blood pressure controlM R Weir, G L BakrisPostgraduate Medicine|February 15, 1992
Risk for renal injury in diabetic hypertensive patients. Pharmacologic approachesM R Weir, G L BakrisPageof 98